Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection

• Autorzy: M. Parczewski , M. Leszczyszyn-Pynka , M. Kaczmarczyk , G. Adler , A. Binczak-Kuleta , B. Loniewska , A. Boron-Kaczmarska , A. Ciechanowicz
• Języki publikacji: EN

Abstrakty

EN

Genetic susceptibility to HIV infection was previously proven to be influenced by some chemokine receptor polymorphisms clustering on chromosome 3p21. Here the influence of 5 genetic variants was studied: D32 CCR5, G(?2459)A CCR5, G190A CCR2, G744A CX3CR1 and C838T CX3CR1. They were screened in a cohort of 168 HIV-1 positive adults [HIV(+) group] and 151 newborns [control group] from northwestern Poland. PCR-RFLP was performed to screen for the variants (except for D32 CCR5 polymorphism, where PCR fragment size was sufficient to identify the alleles) and then electrophoresed on agarose gel to determine fragment size. Distribution of genotypes and alleles was not significantly different between the groups except for the CCR5 polymorphisms, with the D32 allele and the (?2459)A CCR5 allele more frequent among neonates than in the HIV(+) group. No D32/D32 homozygotes were found in the HIV(+) group, but 16.1% were D32/wt heterozygotes. In the control group, 1.3% were D32/D32 homozygotes and 26.0% were D32/wt heterozygotes. Linkage between the chemokine polymorphisms was calculated using the most informative loci for haplotype reconstruction. Haplotypes containing D32 CCR5, 190G CCR2 and 744A CX3CR1 were found to be significantly more common in the control group. This suggests an association between these haplotypes and resistance to HIV-1 infection.

Słowa kluczowe

EN

CHEMOKINE; HAPLOTYPE; HIV INFECTION; POLYMORPHISM; SUSCEPTIBILITY

• Czasopismo: Journal of Applied Genetics
• Rocznik: 2009
• Tom: 50
• Numer: 2
• Strony: 159-165

Twórcy

autor

M. Parczewski

autor

M. Leszczyszyn-Pynka

autor

M. Kaczmarczyk

autor

G. Adler

autor

A. Binczak-Kuleta

autor

B. Loniewska

autor

A. Boron-Kaczmarska

autor

A. Ciechanowicz

• Typ dokumentu: ARTICLE
• Bibliografia: M. Parczewski, Pomeranian Medical University, Department of Infectious Diseases and Hepatology, Arkonska 4, 71-455 Szczecin, Poland